Consider the following statements regarding the 'BIO-NIVESH Platform’ -
- It is a one-time initiative aimed at providing government grants to early-stage biotechnology research projects.
- The platform facilitates direct interactions between biotechnology startups and investors to enable scale-up and commercialisation.
- Startups are selected for participation based on criteria including innovation, market potential, and regulatory readiness.
Select the correct codes from below
Explanation - BIO-NIVESH Platform is aimed at connecting biotechnology startups with investors and increasing private capital for innovations that are ready for scale-up and commercialisation. It is envisaged as a recurring platform, with subsequent editions proposed across different cities to broaden participation. It has been designed as a two-way engagement mechanism which enables innovators to understand the investment lens while giving investors deeper insight into the scientific, regulatory and development pathways of biotechnology. The inaugural BIO-NIVESH edition brought together 20 high-potential biotechnology and deep-tech startups and around 50 investors. The first session featured direct startup-investor interactions, with startups selected on the basis of innovation, development stage, market potential, scalability and regulatory readiness. The second session involved an interaction between minister, investors and startups on access to capital, commercialisation, scale-up and measures to support innovation-led growth. Significance: It would help build the bridge required to take promising ideas from research and entrepreneurship to industry, scale and markets.
Explanation - BIO-NIVESH Platform is aimed at connecting biotechnology startups with investors and increasing private capital for innovations that are ready for scale-up and commercialisation. It is envisaged as a recurring platform, with subsequent editions proposed across different cities to broaden participation. It has been designed as a two-way engagement mechanism which enables innovators to understand the investment lens while giving investors deeper insight into the scientific, regulatory and development pathways of biotechnology. The inaugural BIO-NIVESH edition brought together 20 high-potential biotechnology and deep-tech startups and around 50 investors. The first session featured direct startup-investor interactions, with startups selected on the basis of innovation, development stage, market potential, scalability and regulatory readiness. The second session involved an interaction between minister, investors and startups on access to capital, commercialisation, scale-up and measures to support innovation-led growth. Significance: It would help build the bridge required to take promising ideas from research and entrepreneurship to industry, scale and markets.